-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Pollinex Quattro Grass in Allergic Rhino-Conjunctivitis
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pollinex Quattro Grass in Allergic Rhino-Conjunctivitis Drug Details: Pollinex Quattro Grass is under development...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Pollinex Quattro Tree in Pollen Allergy
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Pollinex Quattro Tree in Pollen AllergyDrug Details:TreeMATA MPL is under development for the treatment of pollen...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – HIL-214 in Gastroenteritis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.HIL-214 in GastroenteritisDrug Details:HIL-214 was under development for the prevention of acute gastroenteritis caused by norovirus....
-
Analyst Opinions
![]()
Game on – Navigating Future-Play in Gaming
Gaming Startups Overview From the explosion of mobile gaming to the transformative power of cloud-based experiences, the gaming industry is becoming more interconnected and immersive. Advanced technologies are adding new dimensions, leading to innovations like AI-driven game testing, ultra-realistic non-player characters (NPCs), and blockchain-powered play-to-earn games. GlobalData's Startup Series report, titled "Game on: navigating future-play in gaming," offers a comprehensive overview of how innovative gaming startups are driving the change across eight emerging trends and their sub-trends within the gaming world....
-
Product Insights
![]()
Manikaran Power – MPL Lithium Refinery – Gujarat
Equip yourself with the essential tools needed to make informed and profitable decisions with our Manikaran Power - MPL Lithium Refinery - Gujarat report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Product Insights
![]()
Orthopedic Prosthetics Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Orthopedic Prosthetics Pipeline Market Report Overview Orthopedic prostheses are artificial mechanical devices used in place of a missing limb or body part. The Orthopedic Prosthetics pipeline market research report provides comprehensive information about the Orthopedic Prosthetics pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Segments · Lower Extremity Prosthetics · Hand Prosthetics · Foot Prosthetics · Knee Prosthetics · Upper Extremity Prosthetics · ...
-
Product Insights
![]()
Upper Extremity Prosthetics Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Upper Extremity Prosthetics Pipeline Market Report Overview Upper Extremity Prosthetics are designed to replace a partially or fully amputated or congenitally absent upper extremity. The upper extremity prosthetics pipeline market research report provides comprehensive information about the upper extremity prosthetics pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Key Segment · Hand Prosthetics · Myoelectric Hand Prosthetics · Mechanical Hand Prosthetics · Shoulder Prosthetics...
-
Company Profile
![]()
Hrvatski Telekom dd – Company Profile
Hrvatski Telekom dd (Hrvatski Telekom), a subsidiary of Deutsche Telekom AG, is a telecommunications services provider that offers fixed line, mobile services, wholesale, internet and data services, IoT services and international communications. It also provides mobile handsets and accessories. The company offers support and cross-segment management functions including treasury, procurement, legal, technology, accounting and other central functions. Hrvatski Telekom also provides IPTV and data transmission services including lease of lines, metro-ethernet, ATM and IP/MPLS. The company operates GSM, and UMTS...
Add to Basket -
Company Profile
![]()
Bharat Sanchar Nigam Ltd – Company Profile
Bharat Sanchar Nigam Ltd (BSNL) is a provider of network management and telecommunications services. The company offers a wide range of telecom services including wire line, GSM mobile, internet, broadband, carrier service, MPLS-VPN, VoIP services, wireline, national long distance, and international long distance services. It also provides radio broadband services (Bharat Air Fibre), including UAN service, toll-free numbers/services, VPN service, and televoting services. Apart from this, BSNL offers enterprise business services, including voice and mobility, internet data center, enterprise data...
Add to Basket -
Company Profile
![]()
TIM SpA – Company Profile
TIM SpA (TIM) is a provider of telecommunications services. The company offers mobile and fixed telecom services, voice, and data, internet, and broadband services. It offers fiber optic data transmission using full IP technology, such as DWDM and MPLS and residential broadband services, through Tim Brasil. The company’s Telecom Italia Sparkle group provide wide variety of services, including international voice, data and internet services for fixed and mobile telecommunication operators. It also serves wholesale market and MNC’s through its own...
Add to Basket -
Sector Analysis
![]()
Myelofibrosis Market Size, Drug Analysis, Epidemiology, Disease Management, Pipeline Assessment, Unmet Needs and Forecast to 2031
Myelofibrosis Market Report Overview The Myelofibrosis market size across the 8MM was valued at $2.39 billion in 2021 and is expected to achieve a CAGR of more than 1% during 2021-2031. Peak-year sales are set to be reached in 2027, driven by the approvals of several promising late-stage pipeline agents and the continued clinical dominance of Jakafi/Jakavi (ruxolitinib). Incyte was the first company to capitalize on the clinical and commercial potential of the MF market with the landmark approval of...
-
Product Insights
![]()
Net Present Value Model: HIL-214
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model HIL-214 Drug Details HIL-214 was under...
-
Product Insights
![]()
Net Present Value Model: TAK-214
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model TAK-214 Drug Details HIL-214 was under...
-
Product Insights
![]()
Net Present Value Model: Mosquirix
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Mosquirix Drug Details Plasmodium falciparum and...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – (plasmodium falciparum + hepatitis B) vaccine
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry (plasmodium falciparum + hepatitis B) vaccine Drug Details Plasmodium falciparum and Hepatitis B vaccine...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – Pollinex Quattro Grass
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry Pollinex Quattro Grass Drug Details Pollinex Quattro Grass is under development for the treatment...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – Pollinex Ragweed
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry Pollinex Ragweed Drug Details Pollinex Ragweed (Pollinex Quattro Ragweed, Ragweed MATA MPL) is under...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – Pollinex Quattro Tree
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry Pollinex Quattro Tree Drug Details TreeMATA MPL is under development for the treatment of...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – HIL-214
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry HIL-214 Drug Details HIL-214 was under development for the prevention of acute gastroenteritis caused...
-
Sector Analysis
![]()
Myelofibrosis Epidemiology Analysis and Forecast, 2021-2031
In the 8MM, there were 69,236 diagnosed prevalent cases of Myelofibrosis (MF) in 2021. MF belongs to a group of diseases called myeloproliferative disorders. MF is a serious bone marrow disorder that disrupts the body’s normal production of blood cells (MedlinePlus, 2020; Mayo Clinic, 2021). MF includes primary MF (PMF), which is idiopathic. At times, essential thrombocytosis (ET) or polycythemia vera (PV) could progress to MF, resulting in post-essential thrombocytosis MF (PET MF) and post-polycythemia vera MF (PPV MF), which...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.